Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). iZafe Group AB's share price for the quarter that ended in Mar. 2025 was kr0.244. iZafe Group AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 310.19 Mil. Therefore, iZafe Group AB's market cap for the quarter that ended in Mar. 2025 was kr75.69 Mil.
iZafe Group AB's quarterly market cap
increased
from Sep. 2024 (kr57.87 Mil) to Dec. 2024 (kr58.98 Mil) and
increased
from Dec. 2024 (kr58.98 Mil) to Mar. 2025 (kr75.69 Mil).
iZafe Group AB's annual market cap
increased
from Dec. 2022 (kr44.75 Mil) to Dec. 2023 (kr72.17 Mil) but then
declined
from Dec. 2023 (kr72.17 Mil) to Dec. 2024 (kr58.98 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. iZafe Group AB's Enterprise Value for Today is kr101.52 Mil.
iZafe Group AB Market Cap Historical Data
The historical data trend for iZafe Group AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of iZafe Group AB's Market Cap
For the Medical Instruments & Supplies subindustry, iZafe Group AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iZafe Group AB's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's Market Cap distribution charts can be found below:
* The bar in red indicates where iZafe Group AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
iZafe Group AB's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iZafe Group AB (OSTO:IZAFE B) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
iZafe Group AB Market Cap Related Terms
Thank you for viewing the detailed overview of iZafe Group AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:IZAFE B has been successfully added to your 